LifeMD receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LifeMD Inc (LFMD)
LifeMD Inc stock price live, this page displays NASDAQ LFMD stock exchange data. View the LFMD premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LifeMD Inc real time stock price chart below.
What Is the LifeMD Inc Stock Price Today?
The LifeMD Inc stock price today is 2.195.
What Is the Stock Symbol for LifeMD Inc?
The stock ticker symbol for LifeMD Inc is LFMD.
Is LFMD the Same as $LFMD?
$LFMD is a common way to refer to the LifeMD Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does LifeMD Inc Trade On?
LifeMD Inc is listed and trades on the NASDAQ stock exchange.
Is LifeMD Inc a Good Stock to Buy?
Determining whether LifeMD Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current LifeMD Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LFMD quote. (ISIN: US53216B1044)
What Is the LifeMD Inc Stock Price Today?
The LifeMD Inc stock price today is 2.195.
What Is the Stock Symbol for LifeMD Inc?
The stock ticker symbol for LifeMD Inc is LFMD.
Is LFMD the Same as $LFMD?
$LFMD is a common way to refer to the LifeMD Inc ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does LifeMD Inc Trade On?
LifeMD Inc is listed and trades on the NASDAQ stock exchange.
Is LifeMD Inc a Good Stock to Buy?
Determining whether LifeMD Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current LifeMD Inc share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LFMD quote. (ISIN: US53216B1044)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.850
2.340
52 wk Range
1.600
5.375
LFMD is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.8502.340
52 wk Range
1.6005.375
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LFMD Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
6.875
Upside
+213.21%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Impressive gross profit margins
Why is LifeMD stock sliding today?- Investing.com
- LifeMD receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 6.875
(+213.21% Upside)
LifeMD Inc SWOT Analysis
AI-Powered Scaling | Learn how LifeMD leverages AI to expand provider capacity and improve drug authorization rates, enhancing operational efficiency |
Financial Forecast | Analysts project 35% revenue growth for FY2024, with adjusted EBITDA margins expected to rise from 8% to 13.5% by FY2025 |
Diversification Drive | Explore LifeMD's expansion into men's health with new HRT and weight management offerings, positioning for cross-selling opportunities |
Telehealth Triumph | LifeMD's Weight Management Program sees explosive growth, doubling subscribers and driving record patient acquisition in Q1 2024 |
LifeMD Inc Earnings Call Summary for Q3/2026
- Q3 revenue of $44.6M missed estimates by $4.27M (8.74%), falling 7% YoY; adjusted EPS of -$0.11 beat forecasts by $0.04
- Shares plunged 16.85% to $1.48 after-hours as company slashed 2026 exit run-rate guidance to $200M from $250M previously
- Adjusted EBITDA improved to -$0.4M from -$3.5M in Q2 as marketing spend dropped 34% sequentially; gross margin fell to 82% from 85%
- LifeMD secured branded GLP-1 fulfillment deals with Novo Nordisk and Eli Lilly; expects 30% revenue growth in 2027 on flat overhead
- Q4 guidance: $46M-$49M revenue, -$4M to -$2M adjusted EBITDA; new peptide offerings and platform redesign planned for early 2027
Last Updated: 11/12/2026, 05:33 PM
Read Full TranscriptLifeMD investor slides for Q3/2026
Last Update: Nov 12, 2026
See full investor slides
Earnings
Latest Release
Nov 12, 2026
EPS / Forecast
-0.11 / -0.15
Revenue / Forecast
44.6M / 48.87M
Compare LFMD to Peers and Sector
Metrics to compare | LFMD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLFMDPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.4x | −0.2x | −0.2x | |
PEG Ratio | −0.06 | 0.00 | 0.00 | |
Price / Book | −183.0x | 1.0x | 2.6x | |
Price / LTM Sales | 0.6x | 1.5x | 2.8x | |
Upside (Analyst Target) | 213.2% | 16.4% | 61.2% | |
Fair Value Upside | Unlock | 31.3% | 9.7% | Unlock |
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men’s telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men’s health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss. The company also provides LifeMD PC, a virtual primary care and telehealth service which is a provider for their primary care, urgent care, and chronic care needs; and offers virtual medical care, including on-demand consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, integration with in-home tools, and more. In addition, it offers GLP-1 for weight management and in-home health monitoring devices. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the LifeMD (LFMD) Stock Price Today?
The LifeMD stock price today is 2.195 USD.
What Stock Exchange Does LifeMD Trade On?
LifeMD is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for LifeMD?
The stock symbol for LifeMD is "LFMD."
What Is the LifeMD Market Cap?
As of today, LifeMD market cap is 106.090M USD.
What Is LifeMD's Earnings Per Share (TTM)?
The LifeMD EPS (TTM) is -0.50.
When Is the Next LifeMD Earnings Date?
LifeMD will release its next earnings report on Mar 15, 2027.
From a Technical Analysis Perspective, Is LFMD a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has LifeMD Stock Split?
LifeMD has split 1 times.
How Many Employees Does LifeMD Have?
LifeMD has 350 employees.
What is the current trading status of LifeMD (LFMD)?
As of Nov 15, 2026, LifeMD (LFMD) is trading at a price of 2.195 USD, with a previous close of 2.195 USD. The stock has fluctuated within a day range of 1.850 USD to 2.340 USD, while its 52-week range spans from 1.600 USD to 5.375 USD.
What Is LifeMD (LFMD) Price Target According to Analysts?
The average 12-month price target for LifeMD is 6.875 USD, with a high estimate of 9 USD and a low estimate of 3 USD. 7 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +213.21% Upside potential.
What Is the LFMD Premarket Price?
LFMD's last pre-market stock price is 1.880 USD. The pre-market share volume is 54,030.000, and the stock has decreased by 0.225, or 13.600%.
What Is the LFMD After Hours Price?
LFMD's last after hours stock price is 2.150 USD, the stock has decreased by -0.045, or -2.050%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.